tiprankstipranks
Ryvu Therapeutics SA (PL:RVU)
:RVU
Poland Market
RVU
Ryvu Therapeutics SA
RESEARCH TOOLSreports

Ryvu Therapeutics SA (RVU) Financial Statements

Compare
0 Followers

Ryvu Therapeutics SA Financial Overview

Ryvu Therapeutics SA's market cap is currently zł506.33M. The company's EPS TTM is zł-0.761; its P/E ratio is -6.19; Ryvu Therapeutics SA is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is zł―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuezł 62.25Mzł 77.97Mzł 46.86Mzł 38.80Mzł 11.19M
Gross Profitzł -117.03Mzł 58.39Mzł 29.31Mzł 21.40Mzł -2.54M
Operating Incomezł -122.15Mzł -122.10Mzł -100.95Mzł -78.42Mzł -103.78M
EBITDAzł -112.71Mzł -96.83Mzł -81.04Mzł -65.21Mzł -65.96M
Net Incomezł -101.23Mzł -111.44Mzł -92.11Mzł -83.78Mzł -79.08M
Balance Sheet
Cash & Short-Term Investmentszł 107.68Mzł 225.40Mzł 233.67Mzł 102.44Mzł 88.23M
Total Assetszł 224.44Mzł 378.78Mzł 403.20Mzł 474.98Mzł 228.81M
Total Debtzł 71.72Mzł 75.51Mzł 906.00Kzł 2.77Mzł 5.07M
Net Debtzł 12.11Mzł -84.56Mzł -57.03Mzł -99.15Mzł -78.17M
Total Liabilitieszł 153.69Mzł 234.89Mzł 143.61Mzł 131.59Mzł 59.39M
Stockholders' Equityzł 53.83Mzł 143.88Mzł 259.59Mzł 343.39Mzł 161.30M
Cash Flow
Free Cash Flowzł -117.75Mzł -135.38Mzł -88.11Mzł 12.03Mzł -69.85M
Operating Cash Flowzł -110.28Mzł -129.48Mzł -84.55Mzł 21.32Mzł -57.87M
Investing Cash Flowzł 13.35Mzł 137.16Mzł -195.54Mzł 690.00Kzł 8.06M
Financing Cash Flowzł -3.05Mzł 94.21Mzł 240.83Mzł -2.46Mzł -3.17M
Currency in PLN

Ryvu Therapeutics SA Earnings and Revenue History

Income Statement >

Ryvu Therapeutics SA Debt to Assets

Balance Sheet >

Ryvu Therapeutics SA Cash Flow

Cash Flow >

Ryvu Therapeutics SA Forecast EPS vs Actual EPS

Earnings >